ImportRefusal LogoImportRefusal

Maharishi Ayurveda Products Pvt. Ltd.

⚠️ High Risk

FEI: 3004401560 • Noida, Uttar Pradesh • INDIA

FEI

FEI Number

3004401560

📍

Location

Noida, Uttar Pradesh

🇮🇳

Country

INDIA
🏢

Address

17 & 18, Noida Special Economic Zone, , Noida, Uttar Pradesh, India

High Risk

FDA Import Risk Assessment

53.0
LowModerateHighCritical

This firm has a significant history of FDA import refusals with notable violations.

Statistics

27
Total Refusals
16
Unique Violations
5/3/2024
Latest Refusal
4/24/2009
Earliest Refusal

Score Breakdown

Violation Severity
55.0×40%
Refusal Volume
53.6×30%
Recency
65.8×20%
Frequency
18.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

26011×

FALSE

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(a)(1 ) of the FD&C Act in that the labeling is false or misleading in any particular.

11810×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

757×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

32806×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.

3362×

INCONSPICU

Information required by the Act to be on the label or labeling does not appear to be conspicuous enough as to render it likely to be read and understood by the ordinary individual under customary conditions of purchase and use.

3212×

LACKS N/C

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(e)(2) of the FD&C Act in that the food is in package form and the label fails to bear an accurate statement of the quantity of the contents in terms of weight, measure, or numerical count in accordance with Section 403(e)(2) of the FD&C Act.

2232×

FALSE

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose labeling appears to be false or misleading.

3352×

LACKS N/C

The article is in package form and appears to not have a label containing an accurate statement of the quantity of the contents in terms of weight, measure or numerical count and no variations or exemptions have been prescribed by regs.

4721×

NO ENGLISH

Required label or labeling appears to not be in English in violation of 21 C.F.R. 201.15(c)(1).

4881×

HEALTH C

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be misbranded in that the label or labeling bears an unauthorized nutrient content/health claim.

2511×

POISONOUS

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to bear or contain a poisonous or deleterious substance which may render the article injurious to health. Contains:

161×

DIRECTIONS

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.

2561×

INCONSPICU

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(f) of the FD&C Act in that any word, statement, or other information required by or under the authority of the FD&C Act to appear on the label or labeling is not prominently placed thereon with such conspicuousness (as compared with other words, statements, designs, or devices, in the labeling) and in such terms as to render it likely to be read and understood by the ordinary individual under customary terms of purchase and use (for example, label contains information in two or more languages but fails to repeat all required information in both languages in accordance with 21 CFR 101.15(c)(2), or label fails to include all required information in English in accordance with 21 CFR 101.15(c)(1), except in the case of articles distributed solely in the Commonwealth of Puerto Rico or in a Territory where the predominant language is one other than English)).

31201×

EPHEDALK

The product is subject to refusal of admission pursuant to Section 801(a)(3) in that it is a dietary supplement or a dietary ingredient that appears to contain ephedrine alkaloids, which presents an unreasonable risk of illness or injury under the conditions of use recommended or suggested in the labeling, or if no conditions of use are suggested in the labeling, under ordinary conditions of use.

3331×

LACKS FIRM

The article is in package form and appears to not bear a label containing the name and place of business of the manufacturer, packer, or distributor.

37411×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(o) in that it is being imported or offered for import into the United States, and the importer, owner, or consignee of such article did not, at the time of offering the article for import, submit to the Secretary a statement that identifies the registration under section 510(i) of the Act of each establishment that with respect to such article is required under such section to register with the Secretary.

Refusal History

DateProductViolationsDivision
5/3/2024
66VAK99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
3280FRNMFGREG
75UNAPPROVED
Division of Northern Border Imports (DNBI)
5/3/2024
66VBJ99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
3280FRNMFGREG
Division of Northern Border Imports (DNBI)
1/23/2024
54FCA99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
75UNAPPROVED
Division of Northern Border Imports (DNBI)
4/24/2023
66VIY99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
3280FRNMFGREG
75UNAPPROVED
Division of Southeast Imports (DSEI)
4/24/2023
66VIY99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
3280FRNMFGREG
75UNAPPROVED
Division of Southeast Imports (DSEI)
4/24/2023
66VIY99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
3280FRNMFGREG
75UNAPPROVED
Division of Southeast Imports (DSEI)
4/5/2018
66YBY99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C.
118NOT LISTED
3280FRNMFGREG
333LACKS FIRM
335LACKS N/C
336INCONSPICU
Division of Southeast Imports (DSEI)
7/28/2017
66YBY99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C.
75UNAPPROVED
Division of Southeast Imports (DSEI)
12/27/2013
62MBL01CAMPHOR (ANTI-PRURITIC)
336INCONSPICU
75UNAPPROVED
Los Angeles District Office (LOS-DO)
9/25/2013
66V99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
Los Angeles District Office (LOS-DO)
8/2/2013
54FEL99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
260FALSE
Chicago District Office (CHI-DO)
8/2/2013
54FEL99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
260FALSE
Chicago District Office (CHI-DO)
8/2/2013
54FCL99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
260FALSE
Chicago District Office (CHI-DO)
8/2/2013
54FCL99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
260FALSE
Chicago District Office (CHI-DO)
8/2/2013
54FCL99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
260FALSE
Chicago District Office (CHI-DO)
8/2/2013
54FCL99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
260FALSE
Chicago District Office (CHI-DO)
8/2/2013
54FCL99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
260FALSE
Chicago District Office (CHI-DO)
8/2/2013
54FCL99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
260FALSE
Chicago District Office (CHI-DO)
8/2/2013
54FCL99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
260FALSE
Chicago District Office (CHI-DO)
8/2/2013
54FCL99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
260FALSE
Chicago District Office (CHI-DO)
8/2/2013
54FCA99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
251POISONOUS
Chicago District Office (CHI-DO)
7/30/2013
54FCA99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
256INCONSPICU
3120EPHEDALK
Chicago District Office (CHI-DO)
5/14/2013
63R06STANNOUS FLUORIDE (DENTAL CARIES PROPHYLACTIC)
118NOT LISTED
16DIRECTIONS
335LACKS N/C
3741FRNMFGREG
472NO ENGLISH
Chicago District Office (CHI-DO)
5/16/2012
54ECT99HERBALS & BOTANICAL TEAS, N.E.C.
488HEALTH C
Los Angeles District Office (LOS-DO)
4/24/2009
54FCY99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
260FALSE
Los Angeles District Office (LOS-DO)
4/24/2009
54FCY99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
118NOT LISTED
223FALSE
321LACKS N/C
Los Angeles District Office (LOS-DO)
4/24/2009
54FCY99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
118NOT LISTED
223FALSE
321LACKS N/C
Los Angeles District Office (LOS-DO)

Frequently Asked Questions

What is Maharishi Ayurveda Products Pvt. Ltd.'s FDA import refusal history?

Maharishi Ayurveda Products Pvt. Ltd. (FEI: 3004401560) has 27 FDA import refusal record(s) in our database, spanning from 4/24/2009 to 5/3/2024.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Maharishi Ayurveda Products Pvt. Ltd.'s FEI number is 3004401560.

What types of violations has Maharishi Ayurveda Products Pvt. Ltd. received?

Maharishi Ayurveda Products Pvt. Ltd. has been cited for 16 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Maharishi Ayurveda Products Pvt. Ltd. come from?

All FDA import refusal data for Maharishi Ayurveda Products Pvt. Ltd. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.